| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 104,068 | 100,835 | 140,689 | 131,153 | | Cost of Revenue | 91,399 | 89,001 | 113,112 | 110,768 | | | Gross Profit | 12,669 | 11,834 | 27,577 | 20,385 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,890 | 19,576 | 23,364 | 20,877 | | Non Recurring | 233 | 2,554 | 9,743 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,454) | (10,296) | (5,530) | (492) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 173 | 215 | 433 | 329 | | Earnings Before Interest And Taxes | (8,281) | (10,081) | (5,097) | (163) | | Interest Expense | 166 | 169 | 168 | 173 | | Income Before Tax | (8,447) | (10,250) | (5,265) | (336) | | Income Tax Expense | (3,168) | (3,844) | (2,332) | (359) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,279) | (6,406) | (2,933) | 23 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,279) | (6,406) | (2,933) | 23 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,279) | ($6,406) | ($2,933) | $23 |
|
0.51% Nasdaq 
Income Statement
